Verily is a subsidiary of Alphabet that is using a data-driven, people-first approach to change the way people manage their health and the way healthcare is delivered. Launched from Google X in 2015, Verily’s purpose is to bring the promise of precision health to everyone, every day. Verily is focused on generating and activating data from a wide variety of sources, including clinical, social, behavioral and the real world, to arrive at the best solutions for a person based on a comprehensive view of the evidence. Verily uses its recognized expertise and capabilities in technology, data science and healthcare to enable the entire healthcare ecosystem to drive better health outcomes.

SignalPath from Verily is a state-of-the-art clinical trial management system (CTMS) for research sites that digitizes study protocols and eliminates siloed manual processes to enable high-quality research and maximize research revenue. Built by researchers, for researchers, SignalPath incorporates proprietary technology that dramatically improves the ease, quality, efficiency and profitability of trial execution. For more information, please visit verily.com/signalpath.